{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T05:57:44Z","timestamp":1785391064248,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,15]],"date-time":"2008-04-15T00:00:00Z","timestamp":1208217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10911-008-9078-4","type":"journal-article","created":{"date-parts":[[2008,4,14]],"date-time":"2008-04-14T18:12:23Z","timestamp":1208196743000},"page":"205-214","source":"Crossref","is-referenced-by-count":38,"title":["The Neuregulin Family of Genes and their Multiple Splice Variants in Breast Cancer"],"prefix":"10.1007","volume":"13","author":[{"given":"Nandini V. L.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Gullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"9078_CR1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","volume":"2","author":"Y Yarden","year":"2001","unstructured":"Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001;2:127\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9078_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biopsych.2005.11.002","volume":"60","author":"PJ Harrison","year":"2006","unstructured":"Harrison PJ, Law A. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006;60:132\u201340.","journal-title":"Biol Psychiatry"},{"key":"9078_CR3","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","volume":"19","author":"MA Olayioye","year":"2000","unstructured":"Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signalling network: receptor heterodimerisation in development and cancer. EMBO J 2000;19:3159\u201367.","journal-title":"EMBO J"},{"key":"9078_CR4","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1074\/jbc.M413919200","volume":"280","author":"BS Kochupurakkal","year":"2005","unstructured":"Kochupurakkal BS, Harari D, Di-Segni A, Maik-Rachline G, Lyass L, Gur G, et al. Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity. J Biol Chem 2005;280:8503\u201312.","journal-title":"J Biol Chem"},{"key":"9078_CR5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1006\/bbrc.1999.1873","volume":"266","author":"T Uchida","year":"1999","unstructured":"Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, et al. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of ErbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999;266:593\u2013602.","journal-title":"Biochem Biophys Res Commun"},{"key":"9078_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1471-4159.2006.03801.x","volume":"98","author":"DA Siegel","year":"2006","unstructured":"Siegel DA, Davies P, Dobrenis K, Huang M. Tomoregulin 2 is found extensively in plaques in Alzheimer\u2019s disease brain. J Neurochem 2006;98:34\u201344.","journal-title":"J Neurochem"},{"key":"9078_CR7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2004.07.066","volume":"321","author":"Y Kinugasa","year":"2004","unstructured":"Kinugasa Y, Ihiguro H, Tokita Y, Oohira A, Ohmoto H, Higashiyama S. Neuroglycan C, a new member of the neuregulin family. Biochem Biophys Res Commun 2004;321:1045\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"9078_CR8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2148-6-79","volume":"6","author":"RA Stein","year":"2006","unstructured":"Stein RA, Staros JV. Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis. BMC Evol Biol 2006;6:79.","journal-title":"BMC Evol Biol"},{"key":"9078_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0014-4827(02)00102-7","volume":"284","author":"D Falls","year":"2003","unstructured":"Falls D. Neuregulins: functions, forms and signalling strategies. Exp Cell Res 2003;284:14\u201330.","journal-title":"Exp Cell Res"},{"key":"9078_CR10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/oxfordjournals.jbchem.a021806","volume":"122","author":"S Higashiyama","year":"1997","unstructured":"Higashiyama S, Horikawa M, Yamada K, Ichino N, Nakano N, Nakagawa T, et al. A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4. J Biochem 1997;122:675\u201380.","journal-title":"J Biochem"},{"key":"9078_CR11","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1128\/MCB.17.7.4007","volume":"17","author":"SJ Busfield","year":"1997","unstructured":"Busfield SJ, Michnick DA, Chickering TW, Revett TL, Ma J, Woolf EA, et al. Characterisation of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol Cell Biol 1997;17:4007\u201314.","journal-title":"Mol Cell Biol"},{"key":"9078_CR12","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1073\/pnas.94.18.9562","volume":"94","author":"D Zhang","year":"1997","unstructured":"Zhang D, Sliwkowski MX, Mark M, Frantz G, Akita R, Sun Y, et al. Neuregulin 3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc Natl Acad Sci U S A 1997;94:9562\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9078_CR13","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/sj.onc.1202631","volume":"18","author":"D Harari","year":"1999","unstructured":"Harari D, Tzahar E, Romano J, Shelly M, Pierce JH, Andrews GC, et al. Neuregulin 4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene 1999;18:2681\u20139.","journal-title":"Oncogene"},{"key":"9078_CR14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/378386a0","volume":"378","author":"D Meyer","year":"1995","unstructured":"Meyer D, Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995;378:386\u201390.","journal-title":"Nature"},{"key":"9078_CR15","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1128\/MCB.24.18.8221-8226.2004","volume":"24","author":"JM Britto","year":"2004","unstructured":"Britto JM, Lukehurst S, Weller R, Fraser C, Qiu Y, Hertzog P, et al. Generation and characterisation of neuregulin-2-deficient mice. Mol Cell Biol 2004;24:8221\u20136.","journal-title":"Mol Cell Biol"},{"key":"9078_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainresrev.2005.11.006","volume":"51","author":"RM Esper","year":"2006","unstructured":"Esper RM, Pankonin MS, Loeb JA. Neuregulins: versatile growth and differentiation factors in nervous system development and human disease. Brain Res Rev 2006;51:161\u201375.","journal-title":"Brain Res Rev"},{"key":"9078_CR17","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.yexcr.2007.03.042","volume":"313","author":"E Iivanainen","year":"2007","unstructured":"Iivanainen E, Paatero I, Heikkinen SM, Junttila TT, Cao R, Klint P, et al. Intra- and extracellular signalling by endothelial neuregulin-1. Exp Cell Res 2007;313:2896\u2013909.","journal-title":"Exp Cell Res"},{"key":"9078_CR18","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.jid.5701118","volume":"128","author":"O Wansbury","year":"2008","unstructured":"Wansbury O, Panchai H, James M, Parry S, Ashworth A, Howard B. Dynamic expression of ErbB pathway members during early mammary gland development. J Invest Dermatol 2008;128:1009\u201321.","journal-title":"J Invest Dermatol"},{"key":"9078_CR19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cne.20016","volume":"472","author":"M Longart","year":"2004","unstructured":"Longart M, Liu Y, Karavanova I, Buonanno A. Neuregulin 2 is developmentally regulated and targeted to dendrites of central neurons. J Comp Neurol 2004;472:156\u201372.","journal-title":"J Comp Neurol"},{"key":"9078_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/387512a0","volume":"387","author":"KL Carraway","year":"1997","unstructured":"Carraway KL, Weber JL, Unger MJ, Ledesma J, Yu N, Gassmann M, et al. Neuregulin-2, a new ligand of ErbB3\/ErbB4-receptor tyrosine kinases. Nature 1997;387:512\u20136.","journal-title":"Nature"},{"key":"9078_CR21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/387509a0","volume":"387","author":"H Chang","year":"1997","unstructured":"Chang H, Riese DJ, Glbert W, Stern DL, McMahan UJ. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997;387:509\u201312.","journal-title":"Nature"},{"key":"9078_CR22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(00)00309-7","volume":"255","author":"K Yamada","year":"2000","unstructured":"Yamada K, Ichino N, Nishii K, Sawada H, Higashiyama S, Ishiguro H, et al. Characterisation of the human NTAK gene structure and distribution of the isoforms for rat NTAK mRNA. Gene 2000;255:15\u201324.","journal-title":"Gene"},{"key":"9078_CR23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mcn.2004.02.002","volume":"26","author":"M Rimer","year":"2004","unstructured":"Rimer M, Prieto AL, Weber AL, Colasante C, ponomareva O, Fromm L, et al. Neuregulin-2 is synthesised by motor neurons and terminal Schwann cells and activates acetylcholine receptor transcription in muscle cells expressing ErB4. Mol Cell Neurosci 2004;26:271\u201381.","journal-title":"Mol Cell Neurosci"},{"key":"9078_CR24","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1242\/jcs.02799","volume":"119","author":"C Carteron","year":"2005","unstructured":"Carteron C, Ferrer-Montiel A, Cabedo H. Characterisation of a neural-specific splicing form of the human neuregulin 3 gene involved in oligodendrocyte survival. J Cell Sci 2005;119:898\u2013909.","journal-title":"J Cell Sci"},{"key":"9078_CR25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/path.1561","volume":"203","author":"M Dunn","year":"2004","unstructured":"Dunn M, Sinha P, Campbell R, Levinson N, Rampaul R, Bates T, et al. Co-expression of neuregulin 1, 2, 3 and 4 in human breast cancer. J Pathol 2004;203:672\u201380.","journal-title":"J Pathol"},{"key":"9078_CR26","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1158\/1078-0432.CCR-06-2237","volume":"13","author":"NVL Hayes","year":"2007","unstructured":"Hayes NVL, Blackburn E, Smart LV, Boyle M, Russell G, Frost T, et al. (2007) Identification and characterisation of novel spliced variants of NRG4 in prostate cancer. Clin Cancer Res 2007;13:3147\u201355.","journal-title":"Clin Cancer Res"},{"key":"9078_CR27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gene.2004.07.029","volume":"342","author":"V Steinthorsdottir","year":"2004","unstructured":"Steinthorsdottir V, Stefansson H, Birgisdottir B, Bjornsdottir S, Fasquel AC, et al. Multiple novel transcription sites for NRG1. Gene 2004;342:97\u2013105.","journal-title":"Gene"},{"key":"9078_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0014-5793(99)00283-5","volume":"447","author":"JT Jones","year":"1999","unstructured":"Jones JT, Akita RW, Sliwkowski MX. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett 1999;447:227\u201331.","journal-title":"FEBS Lett"},{"key":"9078_CR29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3630211","volume":"363","author":"JC Montero","year":"2002","unstructured":"Montero JC, Yuste L, Diaz-Rodriguez E, Esparis-Ogando A, Pandiella A. Mitogen-activated protein kinase-dependent and \u2013independent routes control shedding of transmembrane growth factors through multiple secretases. Biochem J 2002;363:211\u201321.","journal-title":"Biochem J"},{"key":"9078_CR30","doi-asserted-by":"crossref","unstructured":"McGowan PM, McKiernan E, Bolster F, Ryan BM, Hill AD, McDermott EW, et al. ADAM-17 predicts adverse outcome in patients with breast cancer. Ann Oncol. 2008;in press.","DOI":"10.1093\/annonc\/mdm609"},{"key":"9078_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2006.05.024","volume":"10","author":"B-BS Zhou","year":"2006","unstructured":"Zhou B-BS, Peyton MB, He B, Liu C, Girard L, Caudler E, et al. Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 2006;10:39\u201350.","journal-title":"Cancer Cell"},{"key":"9078_CR32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI29518","volume":"117","author":"PA Kenny","year":"2007","unstructured":"Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer. J Clin Invest 2007;117:337\u201345.","journal-title":"J Clin Invest"},{"key":"9078_CR33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.onc.1201317","volume":"15","author":"G Schaefer","year":"1997","unstructured":"Schaefer G, Fitzpatrick VD, Sliwkowski MX. G-Heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Oncogene 1997;15:1385\u201394.","journal-title":"Oncogene"},{"key":"9078_CR34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s004390050961","volume":"104","author":"HZ Ring","year":"1999","unstructured":"Ring HZ, Chang H, Guilbot A, Brice A, LeGuern E, Francke U. The human neuregulin-2 (NRG2) gene: cloning, mapping and evaluation as a candidate for the autosomal recessive form of Charcot\u2013Marie\u2013Tooth disease linked to 5q. Hum Genet 1999;104:326\u201332.","journal-title":"Hum Genet"},{"key":"9078_CR35","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/oxfordjournals.jbchem.a022688","volume":"127","author":"N Nakano","year":"2000","unstructured":"Nakano N, Higashiyama S, Kajihara K, Endo T, Ishiguro H, Yamada K, et al. NTAKa and b isoforms stimulate breast tumour cell growth by means of different receptor combinations. J Biochem 2000;127:925\u201330.","journal-title":"J Biochem"},{"key":"9078_CR36","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1038\/sj.onc.1205960","volume":"21","author":"SS Hobbs","year":"2002","unstructured":"Hobbs SS, Coffing SL, Le ATD, Cameron EM, Williams EE, Andrew M, et al. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 2002;21:8442\u201352.","journal-title":"Oncogene"},{"key":"9078_CR37","first-page":"1061","volume":"13","author":"MM Hijazi","year":"1998","unstructured":"Hijazi MM, Young PE, Dougherty MK, Bressette DS, Cao TT, Pierce JH, et al. NRG-3 in human breast cancers: activation of multiple erbB family proteins. Int J Oncol 1998;13:1061\u20137.","journal-title":"Int J Oncol"},{"key":"9078_CR38","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1101\/gad.338505","volume":"19","author":"B Howard","year":"2005","unstructured":"Howard B, Panchal H, McCarthy A, Ashworth A. Identification of the scaramanga gene implicates neuregulin 3 in mammary gland specification. Genes Dev 2005;19:2078\u201390.","journal-title":"Genes Dev"},{"key":"9078_CR39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.onc.1210689","volume":"27","author":"NV Hayes","year":"2008","unstructured":"Hayes NV, Newsam RJ, Baines AJ, Gullick WJ. Characterization of the cell membrane-associated products of the neuregulin 4 gene. Oncogene 2008;27:715\u201320.","journal-title":"Oncogene"},{"key":"9078_CR40","doi-asserted-by":"crossref","first-page":"19188","DOI":"10.1074\/jbc.270.32.19188","volume":"270","author":"TL Burgess","year":"1995","unstructured":"Burgess TL, Ross SL, Qian YX, Brankow D, Hu S. Biosynthetic processing of neu differentiation factor. Glycosylation, trafficking, and regulated cleavage from the cell surface. J Biol Chem 1995;270:19188\u201396.","journal-title":"J Biol Chem"},{"key":"9078_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0079-6603(08)60055-0","volume":"49","author":"SR Campion","year":"1994","unstructured":"Campion SR, Niyogi SK. Interaction of epidermal growth factor with its receptor. Prog Nucleic Acid Res Mol Biol 1994;49:353\u201383.","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"9078_CR42","doi-asserted-by":"crossref","first-page":"17927","DOI":"10.1074\/jbc.271.30.17927","volume":"271","author":"SA Thompson","year":"1996","unstructured":"Thompson SA, Harris A, Hoang D, Ferrer M, Johnson GR. COOH-terminal extended recombinant Amphiregulin with bioactivity comparable with naturally derived growth factor. J Biol Chem 1996;271:17927\u201331.","journal-title":"J Biol Chem"},{"key":"9078_CR43","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbrc.2006.09.028","volume":"350","author":"K Eto","year":"2006","unstructured":"Eto K, Eda K, Kanemoto S, Abe SI. The immunoglobulin domain is involved in interaction of neuregulin with ErbB. Biochem Biophys Res Commun 2006;350:263\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"9078_CR44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0896-6273(00)80873-9","volume":"25","author":"D Wolpowitz","year":"2000","unstructured":"Wolpowitz D, Mason TBA, Dietrich P, Mendelsohn M, Talmage DA, Role LW. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 2000;25:79\u201391.","journal-title":"Neuron"},{"key":"9078_CR45","doi-asserted-by":"crossref","first-page":"13024","DOI":"10.1073\/pnas.95.22.13024","volume":"95","author":"X Liu","year":"1998","unstructured":"Liu X, Hwang H, Cao L, Buckland M, Cunningham A, Chen J, et al. Domain-specific gene disruption reveals critical regulation of neuregulin signalling by its cytoplasmic tail. Proc Natl Acad Sci U S A 1998;95:13024\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9078_CR46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1083\/jcb.200212085","volume":"161","author":"J Bao","year":"2003","unstructured":"Bao J, Wolpowitz D, Role LW, Talmage DA. Back signalling by the Nrg-1 intracellular domain. J Cell Biol 2003;161:1133\u201341.","journal-title":"J Cell Biol"},{"key":"9078_CR47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.yexcr.2004.05.028","volume":"299","author":"M Golding","year":"2004","unstructured":"Golding M, Ruhrberg C, Sandle J, Gullick WJ. Mapping nucleolar and spliceosome localisation sequences of neuregulin 1-beta3. Exp Cell Res 2004;299:110\u20138.","journal-title":"Exp Cell Res"},{"key":"9078_CR48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2443.2007.01060.x","volume":"12","author":"T Yokozeki","year":"2007","unstructured":"Yokozeki T, Wakatsuki S, Hatsuzawa K, Black RA, Wada I, Sehara-Fujisawa A. Meltrin b (ADAM19) mediates ectodomain shedding of neuregulin b1 in the Golgi apparatus: fluorescence correlation spectroscopic observation of the dynamics of ectodomain shedding in living cells. Genes Cells 2007;12:329\u201343.","journal-title":"Genes Cells"},{"key":"9078_CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10549-005-9073-z","volume":"96","author":"C Marshall","year":"2006","unstructured":"Marshall C, Blackburn E, Clark M, Humphreys S, Gullick WJ. Neuregulins 1\u20134 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast. Breast Cancer Res Treat 2006;96:163\u201368.","journal-title":"Breast Cancer Res Treat"},{"key":"9078_CR50","first-page":"1781","volume":"12","author":"IM Krane","year":"1996","unstructured":"Krane IM, Leder P. NDF\/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 1996;12:1781\u20138.","journal-title":"Oncogene"},{"key":"9078_CR51","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/MCB.21.13.4265-4275.2001","volume":"21","author":"CI Sartor","year":"2001","unstructured":"Sartor CI, Zhou CH, Kozlowska E, Guttridge K, Kawata E, Caskey L, et al. Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol 2001;21:4265\u201375.","journal-title":"Mol Cell Biol"},{"key":"9078_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1541-7786.MCR-05-0016","volume":"4","author":"M Breuleux","year":"2006","unstructured":"Breuleux M, Schoumacher F, Rehn D, Kung W, Mueller H, Eppenberger U. Heregulins implicated in cellular functions other than receptor activation. Mol Cancer Res 2006;4:27\u201337.","journal-title":"Mol Cancer Res"},{"key":"9078_CR53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/gcc.10218","volume":"37","author":"J Adelaide","year":"2003","unstructured":"Adelaide J, Huang HE, Murati A, Alsop AE, Orsetti B, Mozziconacci MJ, et al. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin\/NRG1 gene. Genes Chromosomes Cancer 2003;37:333\u201345.","journal-title":"Genes Chromosomes Cancer"},{"key":"9078_CR54","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1158\/0008-5472.CAN-04-1762","volume":"64","author":"HE Huang","year":"2004","unstructured":"Huang HE, Chin SF, Ginestier C, Bardou VJ, Adelaide J, Iyer NG, et al. A recurrent chromosomal breakpoint in breast cancer at the NRG1\/neuregulin 1\/heregulin gene. Cancer Res 2004;64:6840\u20134.","journal-title":"Cancer Res"},{"key":"9078_CR55","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1038\/sj.onc.1209570","volume":"25","author":"JC Pole","year":"2006","unstructured":"Pole JC, Courtay-Cahen C, Garcia MJ, Blood KA, Cooke SL, Alsop AE, et al. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation. Oncogene 2006;25:5693\u2013706.","journal-title":"Oncogene"},{"key":"9078_CR56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/brst.2000.0182","volume":"10","author":"EH Raj","year":"2001","unstructured":"Raj EH, Skinner A, Mahji U, Nirmala KN, Ravichandran K, Shanta V, et al. Neuregulin1-alpha expression in locally advanced breast cancer. Breast 2001;10:41\u20135.","journal-title":"Breast"},{"key":"9078_CR57","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature05474","volume":"445","author":"NV Sergina","year":"2007","unstructured":"Sergina NV, Rausch M, Wang D, Blair J, Hann B, Shokat KM, et al. Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3. Nature 2007;445:437\u201341.","journal-title":"Nature"},{"key":"9078_CR58","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ccr.2004.06.022","volume":"6","author":"Y Nagata","year":"2004","unstructured":"Nagata Y, Lan K-H, Zhou X, Tan M, Esteva FJ, Sahin AA, et al. PTEN activation contributes to tumour inhibition by Trastuzumab, and loss of PTEN predicts Trastuzumab resistance in patients. Cancer Cell 2004;6:117\u201327.","journal-title":"Cancer Cell"},{"key":"9078_CR59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","volume":"12","author":"K Berns","year":"2007","unstructured":"Berns K, Horlings HM, Hennessy BT, Madiredjo M, Hijmans EM, Beelen K, et al. A functional genetic approach identifies the PI3K pathway as a major determinant of Trastuzumab resistance in breast cancer. Cancer Cell 2007;12:395\u2013402.","journal-title":"Cancer Cell"},{"key":"9078_CR60","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1158\/1078-0432.CCR-07-1401","volume":"13","author":"R Kumar","year":"2007","unstructured":"Kumar R. ErbB-dependent signalling as a determinant of Trastuzumab resistance. Clin Cancer Res 2007;13:4657\u20139.","journal-title":"Clin Cancer Res"},{"key":"9078_CR61","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1158\/1078-0432.CCR-07-0701","volume":"13","author":"CA Ritter","year":"2007","unstructured":"Ritter CA, Perez-Torre M, Rinehart C, Guix M, Dugger T, Engelman JA, et al. Human breast cancer cells selected for resistance to Trastuzumab In vivo overexpress Epidermal Growth Factor Receptor and ErbB ligands and remain dependent on the ErbB receptor network. Clin Cancer Res 2007;13:4909\u201319.","journal-title":"Clin Cancer Res"},{"key":"9078_CR62","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1200\/JCO.2006.08.6850","volume":"25","author":"E Alava de","year":"2007","unstructured":"de Alava E, Ocana A, Abad M, Montero JC, Esparis-Ogando A, Rodriguez CA, et al. Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer. J Clin Oncol 2007;25:2656\u201363.","journal-title":"J Clin Oncol"},{"key":"9078_CR63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.bjc.6603910","volume":"97","author":"AC Hsieh","year":"2007","unstructured":"Hsieh AC, Moasser MM. Targeting HER proteins in cancer therapy and the role of the non-target HER3. Br J Cancer 2007;97:453\u20137.","journal-title":"Br J Cancer"},{"key":"9078_CR64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2007.10.004","volume":"12","author":"BH Park","year":"2007","unstructured":"Park BH, Davidson NE. PI3 kinase activation and response to trastuzumab therapy: what\u2019s neu with herceptin resistance? Cancer Cell 2007;12:297\u20139.","journal-title":"Cancer Cell"},{"key":"9078_CR65","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","volume":"316","author":"JA Engelman","year":"2007","unstructured":"Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park J, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalling. Science 2007;316:1039\u201343.","journal-title":"Science"},{"key":"9078_CR66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/92.8.622","volume":"92","author":"VRJ Schelfhout","year":"2000","unstructured":"Schelfhout VRJ, Coene ED, Delaey B, Thys S, Page DL, De Potter C. Pathogenesis of Paget\u2019s disease: epidermal heregulin-a, motility factor, and the HER receptor family. J Natl Cancer Inst 2000;92:622\u20138.","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-008-9078-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10911-008-9078-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-008-9078-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:38:33Z","timestamp":1559464713000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10911-008-9078-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["9078"],"URL":"https:\/\/doi.org\/10.1007\/s10911-008-9078-4","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]}}}